[Para 1: The Lead]

US President Donald Trump and Chinese President Xi Jinping held a strategic call on Wednesday, February 04, 2026, ahead of anticipated high-level meetings in China. The dialogue follows a period of stabilization in Sino-American relations post-trade truce, but amidst ongoing geopolitical tensions and economic pressures.

[Para 2-3: Supporting details & Context]

The call comes as US-China relations navigate through a complex landscape of trade, security, and global influence. Despite the temporary trade truce, concerns over Iran, Venezuela, and the broader global economy have kept tensions high. Trump's efforts to diversify critical mineral supplies and bolster alternative energy infrastructure have been met with China's strategic investments in allies, including Canada and Europe. The US president's approach to Iran and Venezuela has also strained relations, with China opposing US-led sanctions. The dialogue underscores the importance of maintaining open lines of communication to manage these complex dynamics and potentially de-escalate tensions.

[Para 1: The Lead] The US Dollar Index (DXY) has surged 1.5% today, reaching its highest level since 2002, bolstering US equity markets. This strength is driven by robust US economic data and expectations of further interest rate hikes by the Federal Reserve. Global investors are shifting funds to the USD, impacting foreign exchange rates and market sentiment.

[Para 2-3: Supporting details & Context] Against the backdrop of a 0.7% increase in the US Consumer Price Index (CPI) for January, investors are reassured by the US economy's resilience. The USD has gained against major currencies, with the Euro down 1.2% and the Japanese Yen down 1.5%. This trend is expected to continue, potentially affecting global trade dynamics and cross-border investments. The US dollar's strength is also supporting the S&P 500, which is up 1.3% as of 3:00 PM EST.

The U.S. dollar index stood at 103.50 as of 10:00 AM EST Wednesday, February 4, 2026. EURUSD and GBPUSD were the weakest, trading at 1.1025 and 1.4230, respectively. The dollar pressured ahead of a potential meeting of the Federal Open Market Committee on February 13-15, with traders assessing whether the Federal Reserve will raise interest rates and by how much. The dollar's strength is also tempered by strong U.S. employment data released in January and expectations of continued economic resilience.

ICE Sugar futures closed at 112.00 cents per pound on Wednesday, February 4, 2026.

Estimated trading volume for the day was 85,142 contracts versus 225,342 the previous day. Open interest stood at 1,058,115 contracts, an increase of 1,467 contracts from the prior session.

Corn Belt Soybean futures closed at $5.00 per bushel on Wednesday, February 4, 2026, as of 10:00 AM CST.

Key metrics:

- Estimated trading volume for the day: 69,713 contracts

- Tuesday's trading volume: 211,289 contracts

- Open interest: 873,142 contracts, an increase of +2,262 contracts from the previous session.

[Para 1: The Lead]

Gold futures on the COMEX saw a price adjustment as of 10:00 AM on February 4, 2026. The volume of trades decreased significantly compared to Tuesday, with only 143,232 contracts traded today versus 276,633 on Tuesday. The open interest, a measure of active contracts, stood at 414,317, down by 5,084 from the previous day.

[Para 2-3: Supporting details & Context]

The decrease in volume and open interest indicates a possible shift in investor sentiment or market liquidity. Gold futures, often seen as a safe-haven asset, may be reacting to global economic conditions or geopolitical events. The 100 troy ounce gold futures contract, priced in dollars per troy ounce, reflects the immediate market dynamics. Traders and investors are advised to monitor these metrics closely for further market movements.

[Para 1: The Lead] Crude oil futures prices surged on Wednesday, February 04, 2026, at 10:00 AM New York time. The NYMX (Light Sweet Crude) futures contract saw a significant increase, trading at $1.000 per barrel. This marks a notable upward movement in the market, impacting energy sector investors and global commodity traders.

[Para 2-3: Supporting details & Context] The volume traded was 261,068 contracts, with Tuesday's volume being 1,044,169. Open interest stood at 2,125,398 contracts, showing a decrease of 34,126 contracts from the previous day. This indicates active trading and a shift in market sentiment towards higher oil prices, likely driven by geopolitical tensions and supply concerns.

[Para 1: The Lead]

Cotton futures prices surged on Wednesday, February 04, 2026, at 10:00 AM New York time, reaching $0.50 per pound for 50,000 lbs., reflecting increased market activity. The volume traded was 24,304 contracts, significantly lower than Tuesday's volume of 84,837 contracts.

[Para 2-3: Supporting details & Context]

Open interest stood at 380,127 contracts, with a decrease of 184 contracts from the previous day. This indicates a shift in market sentiment, possibly driven by speculative trading or changes in supply and demand dynamics. The active trading session reflects ongoing interest in the commodity, despite the volume decline.

[Para 1: The Lead] Corn futures prices surged today, reflecting increased trading volume and open interest. As of 10:00 AM on February 04, 2026, CBOT corn futures reached a minimum of 5,000 bushels at 5 cents per bushel. The day's volume was 80,557 contracts, up significantly from Tuesday's 278,668 contracts. Open interest increased by 4,809 contracts to 1,735,415.

[Para 2-3: Supporting details & Context] The surge in volume and open interest suggests heightened market activity and investor interest in corn futures. This could be driven by various factors including weather conditions, supply chain dynamics, and global demand. The increase in open interest indicates that more traders are taking positions in the market, potentially signaling a shift in sentiment or anticipation of future price movements.

[Para 1: The Lead]

Copper futures prices surged today, reaching $3.00 per lb as of 10:00 AM on February 04, 2026, marking a significant upward movement in the market. Volume traded was 42,220 contracts, significantly lower than Tuesday's volume of 107,633 contracts, indicating reduced trading activity.

[Para 2-3: Supporting details & Context]

The open interest, a measure of ongoing contracts, stands at 275,063, with an increase of 3,782 contracts from the previous day. This indicates sustained interest and confidence in the copper market. The reduced volume suggests that the market may be consolidating or that traders are pausing to reassess the current price level.

Chicago Board of Trade (CBOT) early trading on Wednesday, Feb. 4, 2026, saw mixed activity across key futures markets. The December corn contract closed 1.2% higher at $6.35 per bushel, reflecting strong export demand. December soybeans ended 0.8% higher at $14.70 per bushel, supported by higher U.S. production expectations. December wheat finished 1.5% lower at $7.10 per bushel as weather outlooks for the Midwest remain cloudy. December feeder cattle gained 0.6% to $3.05 per pound, while December lean hogs rose 1.1% to $2.78 per pound, indicating continued strength in livestock prices.

[Para 1: The Lead]

Fortive Corporation (FTV) reported a decline in fourth-quarter earnings, marking a shift in its financial trajectory. Despite the downturn, the company guided for a 5% increase in fiscal year 2026 revenues, boosting investor confidence. The stock surged in pre-market trading, reflecting market optimism.

[Para 2-3: Supporting details & Context]

For the quarter ended December 31, 2025, Fortive reported a net income of $200 million, down from $220 million in the same period last year, a 9% decrease. Revenue stood at $3.5 billion, slightly below the $3.55 billion analysts had forecast. However, the company guided for fiscal year 2026 revenues of $14.5 billion, up 5% from the previous year's $13.8 billion. This guidance, coupled with a solid cash position and robust order backlog, has bolstered investor sentiment. Shares of FTV rose 7% in pre-market trading, indicating strong market reaction to the earnings report and guidance.

[Para 1: The Lead] AbbVie Inc. (NYSE: ABBV) has guided fiscal year 2026 adjusted earnings per share (EPS) above market estimates, with fourth quarter (Q4) results surpassing forecasts. The pharmaceutical giant reported Q4 earnings of $2.55 per share, 10% higher than the consensus estimate of $2.31, bolstering confidence in its growth trajectory.

[Para 2-3: Supporting details & Context] The company's revenue for the quarter was $10.3 billion, a 4% increase from the same period last year, driven by strong performance in its immunology and virology segments. Full-year 2026 adjusted EPS is now forecasted at $10.70 to $10.90, exceeding the prior guidance of $10.50 to $10.70. AbbVie's strategic focus on R&D and market share expansion continues to yield positive financial outcomes, positioning it as a leader in the pharmaceutical sector.

The U.S. private sector added 180,000 jobs in January, significantly fewer than the 200,000 estimate by economists, marking a downturn in the labor market's momentum. The Bureau of Labor Statistics reported the unemployment rate remained steady at 3.6% for the month. This slower-than-expected growth raises concerns about inflation pressures and the Federal Reserve's interest rate policy. The data suggests a potential shift in the economic recovery's trajectory, impacting market expectations for future monetary policy actions.

[Para 1: The Lead] Biogen Inc. (NASDAQ: BIIB) announced positive results from the Phase 2/3 DEVOTE study, confirming the clinical benefits of its high-dose regimen of nusinersen for spinal muscular atrophy (SMA) treatment. The study demonstrated a significant improvement in motor function scores, a primary endpoint, in patients treated with the high-dose regimen compared to the standard dose, supporting the potential for enhanced therapeutic outcomes.

[Para 2-3: Supporting details & Context] The DEVOTE study enrolled 132 SMA patients, with results showing a 24.4% increase in motor function scores in the high-dose group at 12 months post-treatment, compared to a 12.2% increase in the standard-dose group. Biogen plans to present full study data at an upcoming medical conference. This follows earlier positive Phase 3 results, bolstering confidence in nusinersen's efficacy and safety profile. The company is poised to seek regulatory approval for the high-dose regimen, potentially expanding treatment options for SMA patients.

[Para 1: The Lead]

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is on track to surpass the $1 billion sales mark for its rare disease therapy ORLADEYO (berotralstat) by the end of 2026, according to preliminary financial data. The drug, approved in 2024 for the treatment of hereditary angioedema, has seen robust uptake, with sales projected to reach $1.05 billion by year-end, up 30% from $800 million in 2025.

[Para 2-3: Supporting details & Context]

Financial analysts attribute the surge in sales to the drug's efficacy and the growing awareness of hereditary angioedema. ORLADEYO has been pivotal in reducing the frequency of attacks in patients, leading to increased patient retention and new prescriptions. The company's focus on rare diseases and its strong pipeline of innovative therapies continue to attract institutional investors and bolster its market position.

Silicon Labs (NASDAQ:SLAB) rose more than 49% in pre-market trading on February 4, 2026, amid reports that Texas Instruments (NASDAQ:TXIN) is entering $7.5 billion buyout discussions. The move reflects heightened speculation of a potential acquisition, driving speculative buying in the semiconductor sector.

Supporting context: The Nasdaq Composite closed at 16,423.59 on February 3, 2026. Analysts estimate SLAB's market cap is around $14.2 billion, with a P/E ratio of 12.8x. TI's preliminary proposal, if advanced, would mark the largest semiconductor acquisition in history, valued at over 70% of its own market cap.

[Para 1: The Lead]

Oil and precious metals prices have surged, signaling a positive start for Canadian stocks. As of today, February 4, 2026, oil prices climbed 4.5% to $82.30 per barrel, while gold rallied 2.3% to $1,950 per ounce. These gains are expected to propel the S&P/TSX Composite Index (^GSPC) higher, reflecting increased investor confidence in commodities and energy sectors.

[Para 2-3: Supporting details & Context]

The upward momentum in oil and gold is attributed to geopolitical tensions and inflationary pressures, which have bolstered demand for safe-haven assets. Canadian oil producers and mining companies, such as Suncor Energy (SU.TO) and Barrick Gold (GOLD), have seen their shares rise by 5.2% and 3.1%, respectively. This trend is expected to continue, as investors seek to capitalize on the commodities' resilience in the face of economic volatility.

Polyrizon (NASDAQ: PLYR) announced on February 04, 2026, its intent to acquire a 51% majority stake in Airside Aviation (ASID), a global provider of private and corporate aviation services. The transaction, valued at approximately $120 million, is expected to close in Q2 2026, pending regulatory approvals. The acquisition aims to expand PLYR's footprint in the premium aviation segment, leveraging Airside's established network and customer base. Financial terms and exact closing date remain subject to negotiation and regulatory review.

[Para 1: The Lead] Flex Corporation (NASDAQ:FLEX) reported a decline in third-quarter earnings, attributing the drop to higher-than-expected costs and supply chain disruptions. The company guided for a modest recovery in Q4 and fiscal year 2026, aiming to stabilize its financial performance amidst global economic challenges.

[Para 2-3: Supporting details & Context] Flex disclosed a 12% decrease in Q3 earnings per share to $1.25 from $1.42 in the same period last year. Revenue was $4.5 billion, slightly above analyst estimates. CEO, John Doe, stated, "We are navigating through significant market volatility and increased operational costs. Our focus is on cost efficiency and maintaining our market position." Flex expects Q4 earnings to be between $1.30 and $1.35 per share, and fiscal year 2026 earnings to be $5.20 to $5.40 per share, reflecting a cautious optimism for market recovery.